Agenus Inc news

   Watch this stock
Showing stories 1 - 10 of about 38   

Articles published

AGEN 2.99 +0.09 (3.10%)
price chart
Agenus Inc - A Potential New Play On Ebola
Shares of Agenus Inc (NASDAQ: AGEN) have moved to the upside in Monday's trade as the company is being mentioned as a potential play on Ebola.
Related articles »  
Rising Stocks: Agenus Inc(NASDAQ:AGEN), RadioShack Corporation(NYSE ...
Agenus Inc(NASDAQ:AGEN) currently has a market capitalization of $184.9 million and 62.68 million tradeable shares. The stock currently has a bid price of $3.00 x 200 and an offer price of $3.18 x 600.
Related articles »  
Fast Moving Stocks: American Airlines Group Inc. (NASDAQ:AAL), Vical ...
Biotech companies and the town of Lexington split the cost for shuttle buses that carry workers from Alewife Station to biotech research parks.
Some biotechs decamp for Lexington, seeking room to grow
Garo Armen, chief executive of Agenus Inc., said the town offers better amenities, such as more restaurants and a nicer hotel nearby, than it did in 2004, when his company signed a 30-year lease there.
Are AgenusInc(AGEN) and Cytokinetics, Inc.(CYTK) Poised For Success In The ...
AgenusInc(NASDAQ:AGEN) is a Massachusetts-based biopharmaceutical company that develops immune-oncology candidates. The company's products include checkpoint modulators, adjuvants, and heat shock protein vaccines.
Related articles »  
Global Therapeutics Market shows a tremendous growth
Companies profiled in the report are Dendreon Corp, Agenus Inc., Bavarian Nordic A/S, Novartis International AG, GlaxoSmithKline plc, Argos Therapeutics Inc., AFFiRiS AG, CEL-SCI Corp, Celldex Therapeutics Inc., GlobeImmune Inc., Cytos Biotechnology ...
5 Companies That Could Develop An Enterovirus Treatment
... foot already in the antiviral, respiratory and/or pediatrics spaces. Even the major drug companies like Bristol-Myers Squibb Co (NYSE: BMY) or Merck & Co.
Related articles »  
The Doctrine Of Obviousness-Type Double Patenting Maintains Its Vitality
Abbvie Inc. v. Kennedy Institute of Rheumatology Trust, Case No. 13-1545 (Fed Cir., Aug. 21, 2014) (Dyk, J.). The Kennedy Institute of Rheumatology owned two patents directed toward methods of treating rheumatoid arthritis by co-administering two drugs ...
US Stock Futures Down Ahead Of Industrial Production Report
US stock futures traded lower in early pre-market trade, ahead of economic data. The Empire State manufacturing index for September will be released at 8:30 a.m.
Related articles »  
Biofuels planned for skies over 2020 Tokyo Olympics
The INAF, founded in May, also includes trading firms, manufacturers and Euglena Co., a start-up company that develops products from euglena, a genus of protists similar to algae. Central government ministries and agencies have joined as observers ...
Related articles »